A Phase 1, Open-Label, PET Study of T2310 & BPN14770
NCT04044781
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Change in Research Direction
Conditions
To Determine Brain Target Occupancy of BPN14770
Interventions
DRUG:
BPN14770, T2310
Sponsor
Tetra Discovery Partners